FIELD: chemistry.
SUBSTANCE: benzamide derivatives are presented by the formula [1] or its salt, where Z is -O-, -NR5-, -S-, -SO-; 1 is 0 or 1; m is 0 or 1; R1 is hydrogen atom, C1-6-alkyl group, R2 is hydrogen atom, hydroxylic group, C1-6- alkyl group, carboxyl group, C1-6-alkoxycarbonyl group or -CONR10R11, or R2 and R1 together form =O; R3 is hydrogen atom or C1-6-alkyl group; R4 is hydrogen atom or halogen atom; V is direct bond or -(CR21R22)n-; P1 and P2 rings are the same or different, and each is aromatic or saturated carbocyclic group, or 5-10-member saturated or unsaturated heterocyclic group containing 1-3 heteroatoms selected out of N, O, S.
EFFECT: obtainment of compound with excellent inhibition effect on vanilloid receptor type 1 activity, efficiency in treatment of diseases involving vanilloid receptor type 1 activity.
17 cl, 56 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
3,4-DIHYDROBENZOXAZINE COMPOUNDS AND VANILLOID RECEPTOR SUBTYPE 1 (VR1) INHIBITORS | 2006 |
|
RU2427579C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
2,4-PYRIMIDINDIAMINE COMPOUNDS HAVING EFFECT IN CASE OF AUTOIMMUNE DISORDERS | 2004 |
|
RU2356901C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
Authors
Dates
2010-06-20—Published
2005-07-14—Filed